ibrance tablet
pfizer canada ulc - palbociclib - tablet - 125mg - palbociclib 125mg - antineoplastic agents
ibrance capsules 100 mg
pfizer pharmaceuticals israel ltd - palbociclib - capsules - palbociclib 100 mg - palbociclib - ibrance is indicated for the treatment of adult patients with hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative advanced or metastatic breast cancer in combination with:- an aromatase inhibitor as initial endocrine-based therapy in postmenopausal women or in men; or- fulvestrant in patients with disease progression following endocrine therapy
ibrance capsules 75 mg
pfizer pharmaceuticals israel ltd - palbociclib - capsules - palbociclib 75 mg - palbociclib - ibrance is indicated for the treatment of adult patients with hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative advanced or metastatic breast cancer in combination with:- an aromatase inhibitor as initial endocrine-based therapy in postmenopausal women or in men; or- fulvestrant in patients with disease progression following endocrine therapy
palbonix 100mg capsule
beacon medicare limited 9/b/2, toyenbee circular road, motijheel, dhaka - palbociclib - capsule - each capsule contains palbociclib inn 100mg - palbociclib
ibrance capsule 100mg
pfizer private limited - palbociclib - capsule - palbociclib 100.000mg
ibrance capsule 125mg
pfizer private limited - palbociclib - capsule - palbociclib 125.000mg
ibrance capsule 75mg
pfizer private limited - palbociclib - capsule - palbociclib 75.000mg
ibrance film coated tablet 100mg
pfizer private limited - palbociclib - tablet, film coated - palbociclib 100 mg
ibrance film coated tablet 125mg
pfizer private limited - palbociclib - tablet, film coated - palbociclib 125 mg
ibrance film coated tablet 75mg
pfizer private limited - palbociclib - tablet, film coated - palbociclib 75 mg